Scholarlink

Background <p>Early identification of high-risk individuals for coronary artery disease (CAD) is critical, especially in acute coronary syndrome (ACS) patients who face elevated risks of adverse cardiovascular events and are in need of intensified secondary prevention. This study aimed to investigate the combined value of the triglyceride-glucose (TyG) index—a surrogate marker of insulin resistance—and the systemic inflammatory response index (SIRI), calculated as (neutrophil count × monocyte count)/ lyphocyte count, in assessing coronary artery stenosis severity, proposing a cost-effective strategy for risk stratification in ACS management.</p> Methods <p>A retrospective cohort study included 415 ACS patients diagnosed by coronary angiography at Beijing University of Chinese Medicine Third Affiliated Hospital (June 2021–February 2024). Patients were stratified into low stenosis (Gensini score &lt; 34, <i>n</i> = 204) and high stenosis (Gensini score ≥ 34, <i>n</i> = 211) groups based on the median Gensini score. Clinical parameters and inflammatory markers were analyzed using logistic regression and ROC curves.</p> Results <p>High stenosis group showed significantly higher TyG (1.95 vs. 1.42, <i>P</i> &lt; 0.001) and SIRI (1.07 vs. 0.75, <i>P</i> &lt; 0.001) than the low stenosis group. Both indices independently associated with severe stenosis (OR = 3.094 and 2.064, <i>P</i> &lt; 0.001). The combined TyG-SIRI model achieved an AUC of 0.744 (sensitivity 61.61%, specificity 72.06%), outperforming individual indices (TyG: 0.715; SIRI: 0.666; Delong's test <i>P</i> &lt; 0.05).</p> Conclusion <p>The combination of TyG and SIRI is strongly associated with coronary stenosis severity in ACS patients, suggesting its potential as a clinically feasible, non-invasive indicator for early risk stratification.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Combined triglyceride-glucose index and systemic inflammation response index are associated with coronary artery stenosis severity in acute coronary syndrome: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月12日

查看全文
  • Yangfeng Xie,
  • Jiale Zhang,
  • Jingyun Jia,
  • Haitian Li,
  • Jinli Sun,
  • Qi Liu,
  • Kunze Li,
  • Xiang Li,
  • Yiru Zhao,
  • Wenbo Han,
  • Shuai Wang,
  • Wenhao Jia,
  • Yunxiao Wang,
  • Jie Li,
  • Buxing Chen,
  • Min Li

摘要

Background

Early identification of high-risk individuals for coronary artery disease (CAD) is critical, especially in acute coronary syndrome (ACS) patients who face elevated risks of adverse cardiovascular events and are in need of intensified secondary prevention. This study aimed to investigate the combined value of the triglyceride-glucose (TyG) index—a surrogate marker of insulin resistance—and the systemic inflammatory response index (SIRI), calculated as (neutrophil count × monocyte count)/ lyphocyte count, in assessing coronary artery stenosis severity, proposing a cost-effective strategy for risk stratification in ACS management.

Methods

A retrospective cohort study included 415 ACS patients diagnosed by coronary angiography at Beijing University of Chinese Medicine Third Affiliated Hospital (June 2021–February 2024). Patients were stratified into low stenosis (Gensini score < 34, n = 204) and high stenosis (Gensini score ≥ 34, n = 211) groups based on the median Gensini score. Clinical parameters and inflammatory markers were analyzed using logistic regression and ROC curves.

Results

High stenosis group showed significantly higher TyG (1.95 vs. 1.42, P < 0.001) and SIRI (1.07 vs. 0.75, P < 0.001) than the low stenosis group. Both indices independently associated with severe stenosis (OR = 3.094 and 2.064, P < 0.001). The combined TyG-SIRI model achieved an AUC of 0.744 (sensitivity 61.61%, specificity 72.06%), outperforming individual indices (TyG: 0.715; SIRI: 0.666; Delong's test P < 0.05).

Conclusion

The combination of TyG and SIRI is strongly associated with coronary stenosis severity in ACS patients, suggesting its potential as a clinically feasible, non-invasive indicator for early risk stratification.